The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Yes indeed Winnie.
GM put money aside to replace tests the NHS said they couldn't use. It is my belief that he was prepared as a goodwill gesture to replace the original Exsig with Promate , the DHSC weren't interested, they had moved onto LFTS. The replacement is not an admission of any guilt it was done to try and ensure continuity of business and to try and ensure the lucrative phase 2 of the contract was signed. That's imo , see also Exmexes earlier post , detailing some of the places Exsig was used , with details provided .
They didn't offer to replace defective tests , they developed Promate, less cumbersome, faster...
there is a huge difference and the govt took it , used it and ordered more but refused to pay for it. See the redacted contract as to what exactly was permissable with regards to new /improved tests / assays.
At some stage most definitely, but how much have they spent to date ? I haven't a scooby. Hopefully after the finance deal completes Liberum will supply some answers. If they are going to put a target price on the share, I'd expect some detail as to how they arrived at that figure.
That valuation is without merit. It is worth nothing until someone makes a firm offer. If IM was worth anything remotely like that figure , we wouldn't be sitting with the current MCAP , nor going thru hoops to get finance sorted.. or paying extortionate rates to Riverstone.
I'd love to see a 100 % sale after court results , pay down a chunk of the debt and avoid dilution via a raise.
As a newbie I have zero interest in IM , didn't invest because of it and would like shot of it to focus on the core business , which I believe has great potential.
Well what an excellent post B2HS2L, nailed it. The only thing I am not certain about is court v settlement. From my perspective it makes little diff to the SP in the interim. A settlement, would not be fast , best offer would not be forthcoming first . If they are negotiating, we may not be aware until very close to the court dates. The only other thing worth considering is that the courts take a dim view of going to full trial, if a reasonable offer has been made and declined ( that is what several lawyers have told me) Don't ask me what is considered reasonable, nor what happens to all the costs or how reputation plays into this.
Would like to think some sussing out ranges , don't doubt what you say. Looking at the transactions over the last few weeks, it is obvious to me what the range is. I don't expect to see any large trades before finance , would love to be proved wrong and a massssssive buy appear. Would be very very suprised to see massive sells as from my inexperienced viewpoint, there us just not the volume nor interest to buy at this level from PI's . A waiting game.
Yes Ventura , I noted that . If a manufacturing fault or design issue than you would have expected a consistent fail rate across all labs , not a range of 10 % to 25 % and no mention of the 7th labs results. Most odd. Without doubt Twigger will have picked up on that .
Lol, be great if they've dug their own grave and the 7th lab was one we trained .
Strange this supposed design manufacturing fault wasn't identified during the 50 training sessions , pretty certain the Nova staff would have noticed pdq if they were getting unexpected results.
Not passing any comment. Operational enhancements π
https://www.linkedin.com/posts/cruise-%26-ferry_refurbishment-begins-on-villa-vie-odyssey-activity-7191428655846227968-OdaH?utm_source=share&utm_medium=member_android